Top Biotechnology & Medical Research stocks in Switzerland
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣38.06bn | 36.65 | 0.76% |
BANBBACHEM HOLDING AG | CH₣6.08bn | 53.93 | 0.99% |
BIONBB Biotech AG | CH₣2.22bn | n/a | 4.94% |
BSLNBasilea Pharmaceutica AG Allschwil | CH₣482.86m | 46.24 | n/a |
IDIAIdorsia | CH₣340.46m | n/a | n/a |
KURNKuros Biosciences AG | CH₣252.78m | n/a | n/a |
XLSXlife Sciences AG | CH₣195.62m | 27.15 | n/a |
MOLNMolecular Partners AG | CH₣110.44m | n/a | n/a |
RLFRELIEF THERAPEUTICS Holding SA | CH₣15.88m | n/a | n/a |
ADXNAddex Therapeutics | CH₣14.18m | n/a | n/a |
EVEEvolva Holding | CH₣6.82m | n/a | n/a |
OBSNObseva SA | CH₣1.03m | 0.32 | n/a |